Challenges in the inpatient education of new onset type 1 DM patients: Can tablet technology be the answer?

Share This Post

Volume 10, Issue S28
October 2019

Abstracts for the 45th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD), October 30-November 2, 2019

Challenges in the inpatient education of new onset type 1 DM patients:
Can tablet technology be the answer?

  1. Cospito1, J. Aisenberg2, I. Brennan2, J. Haugh2, S. Ghanny3

1Hackensack University Medical Center, Hackensack, United States, 2Hackensack University Medical Center, Pediatrics, Hackensack, United States, 3Hackensack Meridian School of Medicine, Pediatrics, Hackensack, United States

Educating patients and families on the management of Type 1 Diabetes Mellitus (DM) has always been a challenge. Some endocrinologists educate patients and families with new onset Type1 DM in the inpatient setting, while others have tried to do this process as an outpatient given the changes in the limits of inpatient coverage. Given the challenges in the education process, we must find new and innovative ways to educate patients and families efficiently. In a world where smartphones and tablets are the main way people access information, medical professionals can integrate these devices into the education of patients. Use of such a platform can make patients and families be more independent in the education process. Objectives: To study whether the use of a tablet platform as an adjunct in the education of patients and families with newly diagnosed Type 1 DM leads to improved understanding of diabetes management.

Newly diagnosed Type 1 DM diabetes patients were randomized, where 50% received traditional diabetes education and the other 50% received the tablet in addition to the traditional diabetes education. The tablet contained modules that taught the various aspects of Type 1 DM care. Each module contains a pre-test to assess the user’s knowledge prior to viewing the modules. The modules have lectures on the topic, as well as instructional video. Following this, there is a post-test to assess the user’s knowledge. Each cohort was then assessed for improvements in HbA1c, incidence of hypoglycemia and phone calls to the office.

Preliminary data has shown that participants who used the tablets had better improvement in HbA1c, less hypoglycemia and called the office less, when compared to the other cohort.

Preliminary data has shown that the use of tablet technology in the education of Type 1 DM patients has led to in better HbA1c improvement, less hypoglycemia and less phone calls to office.


Subscribe To Our Newsletter

More To Explore


Equiva Health Appoints New Chief Operating Officer

NEWS RELEASE – We’re thrilled to welcome Scott Jones to our leadership team. As Equiva COO, Scott will lead operations, product and technology functions, with a focus on expanding capabilities in these areas to enable continued growth. Scott’s experience at various organizations including Fortune 500 and private equity-owned emerging healthcare organizations, aligns squarely to our mission to support our customers in advancing health equity, improving health outcomes and driving financial success.

Case Study

MN nonprofit launches Affordable Connectivity Program oncology initiative to reach medically underserved

CUSTOMER SUCCESS STORY – Gilda’s Club Twin Cities, the Minneapolis-based Cancer Support Community network partner, is using Equiva ACP Connect to enroll qualified individuals in the Affordable Connectivity Program and make digital cancer support resources remotely available to at-risk, under-connected populations via at-home, broadband-enabled tablet devices.

I’d like to learn more.
Please contact me.